Evergreen corporate venture fund of Boehringer Ingelheim. Invests in early-stage biotech startups in oncology, regenerative medicine, infectious diseases, and digital health.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.